Century Therapeutics, Inc. (IPSC)
1.48
+0.11
(+8.03%)
USD |
NASDAQ |
Oct 19, 16:00
1.48
0.00 (0.00%)
After-Hours: 16:14
Century Therapeutics Cash from Operations (Annual) : -103.88M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -103.88M |
| December 31, 2024 | -110.14M |
| December 31, 2023 | -88.57M |
| December 31, 2022 | 13.55M |
| Date | Value |
|---|---|
| December 31, 2021 | -89.79M |
| December 31, 2020 | -41.27M |
| December 31, 2019 | -16.17M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Tenax Therapeutics, Inc. | -35.80M |
| Manhattan Scientifics, Inc. | -- |
| Exicure, Inc. | -8.555M |
| Absci Corp. | -92.92M |
| Celularity, Inc. | -13.25M |